Keeping on schedule

No change to Symbicort scheduling, TGA confirms, however an antihistamine will move to Schedule 3 The TGA has confirmed a previous interim decision to reject the downscheduling of the asthma treatment budesonisde-formoterol (Symbicort). This proposal was to move budesonide and formoterol from Schedule 4 to Schedule 3 when combined in an inhaler, for "use as